Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors

作者: U. Baschant , M. Rauner , E. Balaian , H. Weidner , A. Roetto

DOI: 10.3324/HAEMATOL.2016.144808

关键词: Cell biologyBone marrowChemistryBone remodelingWnt signaling pathwayMesenchymal stem cellStromal cellBiochemistryDeferoxamineHemochromatosisOsteoblast

摘要: Iron overload due to hemochromatosis or chronic blood transfusions has been associated with the development of osteoporosis. However, impact changes in iron homeostasis on osteoblast functions and underlying mechanisms are poorly defined. Since Wnt signaling is a critical regulator bone remodeling, we aimed analyze effects deficiency function, further define role these processes. Therefore, marrow stromal cells were isolated from wild-type mice differentiated towards osteoblasts. Exposure dose-dependently attenuated differentiation terms mineralization osteogenic gene expression, whereas chelation deferoxamine promoted time- dose-dependent manner up 3-fold. Similar results obtained for human cells. To elucidate whether pro-osteogenic effect mediated via signaling, performed profiler array deferoxamine-treated Wnt5a was amongst most highly induced genes. Further analysis revealed induction being up-regulated 2-fold after 48 h at 50 μM deferoxamine. Pathway using specific inhibitors that utilized phosphatidylinositol-3-kinase nuclear factor activated T cell pathways induce expression. Finally, confirmed requirement deferoxamine-mediated osteoblast-promoting by analyzing matrix Wnt5a-deficient The promoting completely abolished Wnt5a−/− Thus, data demonstrate

参考文章(52)
T. L. Clemens, G. Ramaswamy, S. R. Gilbert, X. M. Cao, A. W. Eberhardt, Chao Wan, X. Shen, L. Deng, Y. Wang, R. E. Guldberg, L. C. Gerstenfeld, Z. S. Alaql, K. A. Jacobsen, T. A. Einhorn, Role of hypoxia inducible factor-1α pathway in bone regeneration Journal of Musculoskeletal & Neuronal Interactions. ,vol. 8, pp. 323- 324 ,(2008)
Shu-Han Hsu, Chien-Tsun Chen, Yau-Huei Wei, Inhibitory effects of hypoxia on metabolic switch and osteogenic differentiation of human mesenchymal stem cells Stem Cells. ,vol. 31, pp. 2779- 2788 ,(2013) , 10.1002/STEM.1441
Maddalena Casale, Serena Citarella, Aldo Filosa, Elisa De Michele, Francesco Palmieri, Alfonso Ragozzino, Giovanni Amendola, Umberto Pugliese, Immacolata Tartaglione, Filomena Della Rocca, Patrizia Cinque, Bruno Nobili, Silverio Perrotta, Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. American Journal of Hematology. ,vol. 89, pp. 1102- 1106 ,(2014) , 10.1002/AJH.23844
Matthias W Hentze, Martina U Muckenthaler, Nancy C Andrews, Balancing Acts: Molecular Control of Mammalian Iron Metabolism Cell. ,vol. 117, pp. 285- 297 ,(2004) , 10.1016/S0092-8674(04)00343-5
Margaret M. Harris, Linda B. Houtkooper, Vanessa A. Stanford, Carly Parkhill, Judith L. Weber, Hilary Flint-Wagner, Lauren Weiss, Scott B. Going, Timothy G. Lohman, Dietary Iron Is Associated with Bone Mineral Density in Healthy Postmenopausal Women Journal of Nutrition. ,vol. 133, pp. 3598- 3602 ,(2003) , 10.1093/JN/133.11.3598
Wang Xiao, Fei Beibei, Shen Guangsi, Jiang Yu, Zhang Wen, Huang Xi, Xu Youjia, Iron overload increases osteoclastogenesis and aggravates the effects of ovariectomy on bone mass Journal of Endocrinology. ,vol. 226, pp. 121- 134 ,(2015) , 10.1530/JOE-14-0657
Bin Chen, Yi-Lin Yan, Chen Liu, Lin Bo, Guang-Fei Li, Han Wang, You-Jia Xu, Therapeutic Effect of Deferoxamine on Iron Overload-Induced Inhibition of Osteogenesis in a Zebrafish Model Calcified Tissue International. ,vol. 94, pp. 353- 360 ,(2014) , 10.1007/S00223-013-9817-4
Hui Meng, Fei Li, Rong Hu, Yikai Yuan, Guoqi Gong, Shengli Hu, Hua Feng, Deferoxamine alleviates chronic hydrocephalus after intraventricular hemorrhage through iron chelation and Wnt1/Wnt3a inhibition. Brain Research. ,vol. 1602, pp. 44- 52 ,(2015) , 10.1016/J.BRAINRES.2014.08.039
Alexa Klettner, Stefan Koinzer, Vicki Waetzig, Thomas Herdegen, Johann Roider, Deferoxamine mesylate is toxic for retinal pigment epithelium cells in vitro, and its toxicity is mediated by p38. Cutaneous and Ocular Toxicology. ,vol. 29, pp. 122- 129 ,(2010) , 10.3109/15569521003745685